104 Evaluation of a LightCycler PCR assay for the detection of invasive Aspergillosis in pediatric patients with onco-hematological diseases  by Stenghele, C. et al.
S58 International Journal o[ In[ectious Diseases (2006) 10(Sl ) Abstracts 
103 
Bacterial Blood-Stream Infections in Neutropenic 
Children with Hematologic/Oncologic Disorders 
at a Tertiary Care Centre in Saudi Arabia 
shift to GNB. These results upport he exclusion of 
vancomycin as part of the initial empiric therapy 
regime in febrile neutropenic patients. 
I. Bin-Hussain*, I. Kout[akis-Barron, M. Sa[im, M. A[ 
Hunaiti, S. A[-Jumaah, K. Siddiqui, A. Be[gumi, 
H. E[-So[h. King Faisal Specialist Hospital & 
Research Centre, Riyadh, Saudi Arabia 
Background: The aim of this study is to deter- 
mine predominant pathogens and their susceptibil- 
ity patterns in our pediatric patients with hema- 
tology onco[ogy disorders for proper selection of 
empiric antibiotic therapy. 
Nlethods: Retrospective chart review of chitdren 
with hematotogic/oncotogic d sorders and bac- 
teremia between January 1998 and December 
2005. 
Demographic data, undertying diseases, bacteria[ 
isotates, and antibiotic susceptibitity were re- 
viewed. 
Results: One thousand seventy nine bacteremia 
episodes were identified. The majority of isotates 
were GPC (52%) whereas Gram-negative bacteria 
(GNB) caused five hundred and fourteen episodes 
(48%). The most occurring GPC was coagu[ase nega- 
tive staphylococcus (32%), S. aureus (24%), S. pneu- 
moniae (15%), Enterococcus pp. (13%), and viri- 
dans streptococcus (10%). VRE was not isotated. 
For the Gram-negative isotates the most occur- 
ring were E. coli (23%), K. pneumoniae (19%), 
P. aeruginosa (18%), Enterobacter spp. (9%). The 
percentage of GNB isotates changed over the years 
accounting for 41%, 42%, 48%, 44%, 58%, 49%, 47%, 
and 47% for the years 1998, 1999, 2000, 2001, 
2002, 2003, 2004, and 2005, respectively. The 
sensitivity patterns for the hea[thcare associated 
blood stream infections indicated an increase in 
susceptibility for gentamicin from 60% to 64% to 
74% for 2003, 2004, 2005 respectively; Ceftazidime 
has shown an increase from 77% in 2003 to 85% in 
2004, then a decrease in 2005 to 69%. Cefepime 
sensitivity showed a slight increase from 77% in 
2003 to 81% in 2004 then a decrease to 76% in 2005. 
Tazocin indicates an increase from 58% in 2003, 
64% in 2004 and 80% in 2005. In addition, Amikacin 
shows an increase in sensitivity from 62.5% in 2003 
to 84% in 2004 and 85% in 2005. The changes in 
susceptibility patterns may be due to the change 
in the empirical therapy which occurred in June 
2003 from tazocin and gentamicin to cefepime and 
gentamicin. 
Conclusions: Our results concur with observations 
from other studies that in children with cancer GPC 
is a major causative pathogen of bacteremia, with 
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Evaluation of a LightCycler PCR Assay for the 
Detection of Invasive Aspergillosis in Pediatric 
Patients with Onco-hematological Diseases 
C. Stenghe[e, E. Franchin, E. Ca[ore, R. Mangane[[i, 
I. Cerbaro, R. Cusinato, G. Tride[[o, S. Cesaro*. 
Clinic o[ Pediatric Hematology Oncology, Via 
Giustiniani 3, 35128 Padova, Italy 
Background: Invasive Aspergi[[osis (IA) is associ- 
ated with high mortatity. Successfu[ outcome with 
treatment is [inked to earty diagnosis, but cutture 
and histotogy are [ate positive, whereas ctinicat- 
radiotogica[ signs do not arrow a certain diagnosis. 
Objective: To evatuate the rote of LightCycter PCR 
in the early diagnosis of IA in pediatric patients 
who underwent high doses of chemiotherapy or
hematopoietic stem cet[ transptantation; further- 
more, to evatuate sensitivity, specificity, PPV and 
NPV of LightCyc[er PCR compared to ELISA test for 
detection of gatactomannan tigen (GM test). 
Methods: 96 patients (mean age 10 years) at high 
risk for funga[ infection or with suspected fun- 
ga[ infection underwent clinical, radio[ogica[ and 
microbiological evaluations from January 2004 to 
October 2005. Microbiotogica[ evatuations inctuded 
GM test and LightCyc[er PCR test for funga[ DNA in 
brood. A tota[ of 579 brood samptes were corrected 
and examined by LightCyc[er PCR with FRET (Fluo- 
rescence Resonance Energy Transfer) technique, a
very specific method. 
Results: 9/96 (9.4%) patients developed IA, c[as- 
sifted as 5 proven, 3 probabte and 1 possibte 
(EORTC/MSG criteria). Sensitivity, specificity, PPV 
and NPV of LightCyc[er PCR were respectively 
87.5%, 56.32%, 15.55% and 98% when 1 positive 
sampte was sufficient o consider the test positive, 
and 62.5%, 86.2%, 29.41% and 96.15% when at [east 
2 positive samptes were required to consider the 
test positive. Sensitivity, specificity, PPV and NPV 
of GM test were respectively 50%, 96.2%, 57.14% 
and 95.06% when 1 positive sample was sufficient 
to consider the test positive, and 50%, 100%, 100% 
and 95.23% when at [east 2 positive samptes were 
required to consider the test positive. Considering 
a positive resutt from GM or LightCycter PCR test 
(and 2 consecutive positive samptes as criterium for 
positivity), the sensitivity, specificity, PPV and NPV 
were 75%, 85.18%, 33.33% and 97.18% respectively. 
Conclusions: LightCyc[er PCR had a good sensitivity 
and a high NPV: if negative, IA is unlikely; GM test 
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is Less sensitive but has a higher specificity and 
PPV than PCR. One possible future scenario is the 
combined use of both tests to design a strategy of 
pre-emptive antifungaL therapy in order to select 
the patients who do not need of early empirical 
treatment. 
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Trend Towards Reduced Burden of 
Proven/Probable Invasive Fungal Infections (IFI) 
in Adult Non-AIIo-HSCT Neutropenic Patients 
with Acute Leukemia 
L. Senn*, J.O. Robinson, T. CaLandra, O. Marchetti. 
Infectious Diseases Service, EHUV, Lausanne, 
Switzerland 
Background: In Leukemic patients IFI are associ- 
ated with severe morbidity and high mortality (30 
to 90%). Moreover, IFI may have a negative impact 
on treatment and outcome of Leukemia. Recent 
progresses in diagnosis and management of IFI may 
have improved outcome. 
Objectives: To evaluate the morbidity and mortaL- 
ity of proven/probabLe IFI in adult non-aLLo-HSCT 
neutropenic patients with acute Leukemia. 
Methods: CLinicaL, radioLogicaL, and Laboratory 
data were prospectively coLLected in consecu- 
tive neutropenic patients with acute Leukemia 
(2002-2005). Antifunga[ prophylaxis was not used 
routinely. IFI were classified as proven, probable, 
or possible (EORTC-BAMSG). Proven/probabLe IFI 
cases were compared to controls (no IFI). 
Results: 157 neutropenic episodes (91 induction 
chemotherapy, 64 consolidation, 2 auto-HSCT) oc- 
curred in 86 patients (73 AML, 13 ALL). Median age 
was 57yr (range 19-77). IFI was proven/probabLe in 
26 cases (14 aspergillosis, 14 candidiasis, including 
2 mixed IFI) and possible in 28. Proven/probabLe IFI 
occurred during induction chemotherapy in 69% of 
cases. At admission neutropenia was present in 
27% of IFI cases. Median days of in-hospitaL neu- 
tropenia were 25 (range 16-71) vs. 20 (range 
7-59), respectively (p<0.05). AntifungaL therapy 
was started after a median of 3 clays (range 0-13) 
after fever onset. Initial antifungaL therapy con- 
sisted of ampho B-deoxychoLate (n= 17), voricona- 
zoLe (n = 5), caspofungin (n = 2), fluconazoLe (n = 2). 
Criteria for proven/probabLe IFI were met a median 
of 12 clays (range 1-51 ) after fever onset. Morbidity 
and mortality in proven/probabLe IFI (n = 26) cases 
versus controls (n = 103, no IFI) were as foLLows: Me- 
dian clays of hospital stay (range): 43 (26-90)* vs 32 
(16-68), P < 0.05 (*4 patients had thoracic surgery). 
Median days between recovery from neutropenia 
and next chemotherapy (range): 15 (11-45) vs 11 
(1-53), P < 0.05. Patients requiring ICU: 4 (15%) vs 
9 (9%), NS. ICU because of IFI: 2 (8%). MortaLity: 
3 (11.5%) vs 2 (2%), NS. MortaLity due to IFI: 1 (4%). 
Conclusions: In adult non-aLLo-HSCT patients with 
acute Leukemia and neutropenia, proven/probabLe 
IFI were associated with moderate morbidity (Low 
rate of ICU admission, minimal delay of initiation 
of next chemotherapy) and tow attributable mor- 
tality (4%) despite prolongation of hospital stay, 
suggesting a trend towards reduced burden of IFI. 
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Nosocomial Candidemia over a 6-year Period at 
a Medical School Hospital in Japan 
Y. Horiguchi*, Y. Oka, G. Hashikita, S. Takahashi, 
K. Okada, A. Kurita, T. Yamazaki, S. Maesaki. 
1Department of Infectious Disease and Infection 
Control, Saitama Medical School Hospital, 
Saitama, Japan, 2Central Clinical Laboratory, 
Saitama Medical School Hospital, Saitama, 
Japan, 3Department of Medicine, Sanai Hospital, 
Hachiouji, Tokyo, Japan 
Background: BLoodstream infections due to Can- 
dida species are becoming increasingly important 
causes of morbidity and mortality in immunocom- 
promised and other severely iLL patients. 
Objective: The aim of this study was to evaluate 
the incidence of nosocomiaL candidemia among 
patients admitted to our hospitaL. Cases included 
patients undergoing most medical and surgical in- 
terventions. 
Causative pathogens, potential predisposing fac- 
tors, treatment, and risk factors for death were 
also evaluated. 
Methods: Demographic information, risk factors, 
therapy and outcome of aLL patients who con- 
tracted candidemia at Saitama Medical School Hos- 
pital from January 2000 to December 2005 were 
identified through the records of the department of 
CLinicaL MicrobioLogy and reviewed retrospectively. 
Cases of candidemia were dated to the first isoLa- 
tion of any Candida spp. from the patient's blood 
culture. 
Results: A total of 104 episodes of Candida 
bloodstream infections occurring in 104 adult pa- 
tients were identified. In this retrospective study, 
the average incidence of candidemia was 0.38 
cases per 10,000 patient-days. The candidemia pa- 
tient population comprised 68 males and 36 fe- 
males, with a mean age of 67 years. Among 
these patients (n=104), the most frequent un- 
derlying diseases/conditions were neopLasia (41%) 
and cardio-vascuLar diseases (36%). Candida al- 
bicans was the most frequently isolated species 
